US Stock MarketDetailed Quotes

IRTC iRhythm Technologies

Watchlist
  • 112.110
  • -0.080-0.07%
Close Feb 14 16:00 ET
  • 112.110
  • 0.0000.00%
Post 16:27 ET
3.51BMarket Cap-23.12P/E (TTM)

About iRhythm Technologies Company

iRhythm Technologies, Inc. is a digital healthcare company, which engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.

Company Profile

SymbolIRTC
Company NameiRhythm Technologies
Listing DateOct 20, 2016
Issue Price17.00
Founded2006
CEOMr. Quentin S. Blackford
MarketNASDAQ
Employees2000
Fiscal Year Ends12-31
Address699 8th Street,Suite 600
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94103
Phone1-415-632-5700

Company Executives

  • Name
  • Position
  • Salary
  • Quentin S. Blackford
  • Director, President and Chief Executive Officer
  • 16.60M
  • Marc Rosenbaum
  • Senior Vice President, Finance and Chief Accounting Officer
  • --
  • Daniel G. Wilson
  • Chief Financial Officer
  • --
  • Sumi Shrishrimal
  • Executive Vice President and Chief Risk Officer
  • --
  • Patrick M. Murphy
  • Chief Business Officer and Chief Legal Officer
  • 5.33M
  • Dr. Minang Turakhia, M.D.
  • Chief Medical Officer, Chief Scientific Officer and Executive Vice President, Product Innovation
  • 5.32M
  • Chad Patterson
  • Chief Commercial Officer
  • 5.77M
  • Mervin Smith
  • Executive Vice President, Business Operations
  • --
  • Abhijit Y. Talwalkar
  • Chairman of the Board
  • 286.74K
  • Mark J. Rubash
  • Independent Director
  • 248.12K
  • Brian B. Yoor
  • Independent Director
  • 299.68K
  • Bruce G. Bodaken
  • Independent Director
  • 240.25K
  • Dr. Cathleen Noel Bairey Merz
  • Independent Director
  • 230.62K
  • Mojdeh Poul
  • Independent Director
  • 299.68K
  • Karen L. Ling
  • Independent Director
  • 239.97K
  • Dr. Ralph Snyderman,M.D.
  • Independent Director
  • 233.12K

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More